Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin
- 1 December 2017
- journal article
- review article
- Published by Informa UK Limited in Pharmacogenomics
- Vol. 18 (18), 1683-1695
- https://doi.org/10.2217/pgs-2017-0125
Abstract
Aminoglycosides and the anticancer drug cisplatin can cause permanent hearing loss, which impacts patients’ quality of life and results in considerable subsequent costs. Since patients’ individual susceptibility to aminoglycoside- and cisplatin-induced ototoxicity varies considerably, strategies are needed to identify patients at risk, who may require alternative treatments or specific protection strategies. For both drugs, various genetic variants were linked to an increased or decreased risk for ototoxicity. Except for the association between the A1555G mitochondrial DNA mutation and aminoglycoside ototoxicity, their evidence is considered low because study cohorts were often small and replication studies either missing or contradictory. This review summarizes the pharmacogenetic markers linked to aminoglycoside- or cisplatin-induced ototoxicity and discusses reasons for replication failure and future perspective.Keywords
This publication has 76 references indexed in Scilit:
- New developments in aminoglycoside therapy and ototoxicityHearing Research, 2011
- Systemic aminoglycosides are trafficked via endolymph into cochlear hair cellsScientific Reports, 2011
- Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer ChemotherapyMetal-Based Drugs, 2010
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer DrugsMolecular Pharmacology, 2010
- Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing lossMitochondrion, 2010
- Identification of Genetic Variants Contributing to Cisplatin-Induced Cytotoxicity by Use of a Genomewide ApproachAmerican Journal of Human Genetics, 2007
- Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione S-Transferase Genotypes in Testicular Cancer SurvivorsJournal of Clinical Oncology, 2007
- Mutation in TRMU Related to Transfer RNA Modification Modulates the Phenotypic Expression of the Deafness-Associated Mitochondrial 12S Ribosomal RNA MutationsAmerican Journal of Human Genetics, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003